Please see the cover up from the testimony of Doctor to the FDA for EUA on children as young as 5.
The new document warns medical staff, but not the general public, to bear in mind that, according to the May document, following administration of the Pfizer mRNA vaccine, there is “an increased risk of the development of inflammation of the heart muscle [myocarditis]”.
Problematic testimony by Israel’s head of Public Health Services
In a discussion before the Advisory Committee of the U.S. Food and Drug Administration (FDA) on September 17, 2021, several months after her Health Ministry's warning of increased risk of myocarditis after the Pfizer shots, and after most of the 162 cases of post-vaccination myocarditis were discovered, Dr. Elroy-Preis reported that Israel’s vaccine campaign led to just one case of myocarditis after three million people received a third (booster) dose. Elroy-Preis apparently failed to mention the more than 100 confirmed cases that followed the first
Prior doubts about Elroy-Preis’s reliability
Elroy-Preis’s claims are all the more concerning considering that the FDA committee before which she testified was convened specifically to consider Pfizer-BioNTech’s request to amend the Emergency Use Authorization (EUA) for its vaccine to include children aged 5 to 11.